'Omic approaches to preventing or managing metastatic breast cancer

Obi L. Griffith, Joe Gray

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Early detection of metastasis-prone breast cancers and characterization of residual metastatic cancers are important in efforts to improve management of breast cancer. Applications of genome-scale molecular analysis technologies are making these complementary approaches possible by revealing molecular features uniquely associated with metastatic disease. Assays that reveal these molecular features will facilitate development of anatomic, histological and blood-based strategies that may enable detection prior to metastatic spread. Knowledge of these features also will guide development of therapeutic strategies that can be applied when metastatic disease burden is low, thereby increasing the probability of a curative response.

Original languageEnglish (US)
Article number230
JournalBreast Cancer Research
Volume13
Issue number6
DOIs
StatePublished - Dec 8 2011

Fingerprint

Breast Neoplasms
Residual Neoplasm
Genome
Neoplasm Metastasis
Technology
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

'Omic approaches to preventing or managing metastatic breast cancer. / Griffith, Obi L.; Gray, Joe.

In: Breast Cancer Research, Vol. 13, No. 6, 230, 08.12.2011.

Research output: Contribution to journalArticle

@article{346668a391b244d98b2b61dc112dd89e,
title = "'Omic approaches to preventing or managing metastatic breast cancer",
abstract = "Early detection of metastasis-prone breast cancers and characterization of residual metastatic cancers are important in efforts to improve management of breast cancer. Applications of genome-scale molecular analysis technologies are making these complementary approaches possible by revealing molecular features uniquely associated with metastatic disease. Assays that reveal these molecular features will facilitate development of anatomic, histological and blood-based strategies that may enable detection prior to metastatic spread. Knowledge of these features also will guide development of therapeutic strategies that can be applied when metastatic disease burden is low, thereby increasing the probability of a curative response.",
author = "Griffith, {Obi L.} and Joe Gray",
year = "2011",
month = "12",
day = "8",
doi = "10.1186/bcr2923",
language = "English (US)",
volume = "13",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "6",

}

TY - JOUR

T1 - 'Omic approaches to preventing or managing metastatic breast cancer

AU - Griffith, Obi L.

AU - Gray, Joe

PY - 2011/12/8

Y1 - 2011/12/8

N2 - Early detection of metastasis-prone breast cancers and characterization of residual metastatic cancers are important in efforts to improve management of breast cancer. Applications of genome-scale molecular analysis technologies are making these complementary approaches possible by revealing molecular features uniquely associated with metastatic disease. Assays that reveal these molecular features will facilitate development of anatomic, histological and blood-based strategies that may enable detection prior to metastatic spread. Knowledge of these features also will guide development of therapeutic strategies that can be applied when metastatic disease burden is low, thereby increasing the probability of a curative response.

AB - Early detection of metastasis-prone breast cancers and characterization of residual metastatic cancers are important in efforts to improve management of breast cancer. Applications of genome-scale molecular analysis technologies are making these complementary approaches possible by revealing molecular features uniquely associated with metastatic disease. Assays that reveal these molecular features will facilitate development of anatomic, histological and blood-based strategies that may enable detection prior to metastatic spread. Knowledge of these features also will guide development of therapeutic strategies that can be applied when metastatic disease burden is low, thereby increasing the probability of a curative response.

UR - http://www.scopus.com/inward/record.url?scp=84855273946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855273946&partnerID=8YFLogxK

U2 - 10.1186/bcr2923

DO - 10.1186/bcr2923

M3 - Article

C2 - 22216753

AN - SCOPUS:84855273946

VL - 13

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 6

M1 - 230

ER -